Characterization of vasoactive intestinal peptide receptors on human megakaryocytes and platelets

Blood

Volumn 87, Issue 11, 1996, Pages 4629-4635

  Park, Sang K ^a   Olson, Thomas A ^a,b   Ercal, Nuran ^a   Summers, Monica ^a   O'Dorisio, M Sue ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR;

ARTICLE; GROWTH REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE MEMBRANE; THROMBOCYTOPOIESIS;

EID: 0029953824     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.11.4629.bloodjournal87114629     Document Type: Article

References (43)

1. Said SI: Vasoactive intestinal peptide. J Endocrinol Invest 9:191, 1986
2. Said SI, Mutt V: Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon. Eur J Biochem 28:199, 1972
3. Laburthe M, Dupont C: VIPdergic control of intestinal epithelium in health and disease, in Said SI (ed): Vasoactive Intestinal Peptide, New York, NY, Raven Press, 1982, p 407
4. Chen F, O'Dorisio MS: Peptidergic regulation of mucosal immune function, in Brown DR, Alemayehu A (eds): Handbook of Experimental Pharmacology, vol 106. New York, NY, Springer-Verlag, 1993, p 363
5. McGillis JP, Mitsuhashi M, Payan DG: Immunomodulation by Tachykinin Neuropeptides, in O'Dorisio MS, Panerai AE (eds): Neuropeptides and Immunopeptides: Messengers in a Neuroimmune Axis, New York, NY, New York Academy of Sciences, 1990, p 1
6. Payan DG, Brewster DR, Missirian-Bastian A, Goetzl EJ: Substance P recognition by a subset of human T lymphocytes. J Clin Invest 74:1532, 1984
7. Nguyen TT, Krco CJ, Gores A, Go VLW: Analysis of the immunomodulatory peptides of the secretin-glucagon family of peptides on mouse lymphoid cell functions and the demonstration of specific receptors on T cells. Immunol Invest 16:555, 1987
8. Fais S, Annibale B, Boirivant M, Santoro A, Pallone F, Delle Fave G: Effects of somatostatin on human intestinal lamina propria lymphocytes. J Neuroimmunol 31:211, 1991
9. Wiik P, Opstad PK, Boyum A: Binding of vasoactive intestinal peptide (VIP) by human blood monocytes: Demonstration of specific binding sites. Regul Pep 12:145, 1985
10. Stanisz AM, Befus D, Bienenstock J: Differential effects of vasoactive intestinal peptide, substance P, and somatostatin on immunoglobulin synthesis and proliferations by lymphocytes from Peyer's patches, mesenteric lymph nodes, and spleen. J Immunol 136:152, 1986
11. Payan DG, Brewster DR, Goetzel EJ: Specific stimulation of human T lymphocytes by substance P. J Immunol 131:1613, 1983
12. Rameshwar P, Gascon P, Ganea D: Immunoregulatory effects of neuropeptids. Stimulation of interleukin-2 production by Substance P. J Neuroimmunol 37:65, 1992
13. Rameshwar P, Ganea D, Gacon P: Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol 4044, 1994
14. Rameshwar P, Ganea D, Gascon P: In vitro stimulatory effect of Substance P on hematopoiesis. Blood 81:391, 1993
15. Goetzl EJ, Payan DG: Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol 133:3255, 1984
16. Moore RN, Osmand AP, Dunn JA, Joshi JG, Rouse BT: Substance P augmentation of CSF-1-stimulated in vitro myelopoiesis. J Immunol 141:2699, 1988
17. Ericsson A, Schalling M, McIntyre KR, Lundberg JM, Larhammar D, Seroogy K, Hokfelt T, Persson H: Detection of neuropeptide Y and its mRNA in megakaryocytes: Enhanced levels in certain autoimmune mice. Proc Natl Acad Sci USA 84:5585, 1987
18. Gladwin AM, Beesley JE, Harris CJ, Martin JF: Ultrastructural localization of neuropeptide Y in human megakaryocytes and platelets. Nouv Rev Fr Hematol 31:231, 1989
19. Cox CP, Linden J, Said SI: VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). Peptides 5:325, 1984
20. Ercal N, O'Dorisio MS, Vinik A, O'Dorisio TM, Kadrofske M: Vasoactive intestinal peptide receptors in human platelet membrane: Characterization of binding and functional assay. Ann N Y Acad Sci 527:663, 1988
21. Mazur EM, South K: Human megakaryocyte colony-stimulating factor in sera from aplastic dogs; partial purification, characterization, and determination of hematopoietic cell lineage specificity. Exp Hematol 13:1154, 1985
22. Olson TA, Levine RF, Mazur EM, Wright DG, Salvado AJ: Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol 14:241, 1992
23. Sato T, Fuse A, Eguchi M, Yasuhide H, Ryo R, Adachi M, Kishimoto Y, Teramura M, Mizoguchi H, Shima Y, Komori I, Sunami S, Okimoto Y, Nakajima H: Establishment of a human leukaemic cell line (CMK) with megakaryocytic characterics from a Down's syndrome patient with acute megakaryoblastic leukaemia. Br J Haematol 72:184, 1989
24. Komatsu N, Suda T, Moroi M, Tokuyama N, Sakata Y, Okada M, Nishida T, Hirai Y, Sato T, Fuse A, Miura Y: Growth and differentiation of a human megakaryoblastic cell line, CMK. Blood 74:42, 1989
25. Methia N, Louache F, Vainchenker W, Wendling F: Oligodeoxynucleotides antisense to the proto-oncogene c-mpl specifically inhibit in vitro megakaryocytopoiesis. Blood 82:1395, 1993
26. Poncz M, Surrey S, LaRacco P, Weiss MJ, Rappaport EF, Conway TM, Schwartz E: Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood 69:219, 1987
27. Sreedharan SP, Patel DR, Huang JX, Goetzl EJ: Cloning and functional expression of a human neuroendocrine vasoactive intestinal peptide receptor. Biochem Biophys Res Commun 193:546, 1993
28. Sreedharan SP, Huang J-X, Cheung MH, Goetzl EJ: Structure, expression, and chromosomal localization of the type I human vasoactive intestinal peptide receptor gene. Proc Natl Acad Sci USA 92:2939, 1995
29. DeLamarter JF, Buell GN, Kawashima E, Polak JM, Bloom SR: Vasoactive intestinal peptide: expression of the prohormone in bacteria cells. Peptides 6:95, 1985
30. Svoboda M, Tastenoy M, VanRampelberg J, Goossens JF, DeNeff P, Waelbreck M, Robberecht P: Molecular cloning and functional characterization of a human VIP receptor from SUP-T1 lymphoblasts. Biochem Biophys Res Commun 205:1617, 1994
31. Cornwell RD, Gollahon KA, Hickstein DD: Description of the leukocyte function-associated antigen 1 (LFA-1 or CD11a) promoter. Proc Natl Acad Sci USA 90:4221, 1993
32. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989
33. Baenzinger NL, Majerus PN: Isolation of human platelets and platelet surface membranes. Methods Enzymol 31:149, 1974
34. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurements with a folin phenol reagent. J Biol Chem 193:265, 1951
35. Wood CL, O'Dorisio MS: Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts. J Biol Chem 260:1243, 1985
36. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
37. Couvineau A, Rouyer-Fessard C, Darmoul D, Maorett JJ, Carrero I, Ogier-Denis E, Laburthe M: Human intestinal VIP receptor: cloning and functional expression of two cDNA endocrine proteins with different N-terminal domains. Biochem Biophys Res Commun 200:769, 1994
38. Broekman MJ, Handin RJ, Cohen P: Distribution of fibrinogen, and platelet factor 4 and XIII in subcellular fractions of human platelets. Br J Haematol 31:51, 1975
39. Breton-Gorius J, Vainchenker W: Expression of platelet proteins during the in vitro and in vivo differentiation of megakaryccytes and morphological aspects of their maturation. Semin Hematol 23:43, 1986
40. Marcum JA, McKenney JB, Rosenberg RD: Acceleration of thrombin-antithrombin complex formation in rat hindquarters via heparinlike molecules bound to the endothelium. J Clin Invest 74:341, 1984
41. Gewirtz AM, Calabretta B, Rucinski B, Niewiarowski S, Xu YW: Inhibition of human megakaryocytopoiesis in vitro by platelet factor 4 (PF4) and a synthetic COOH-terminal PF4 peptide. J Clin Invest 83:1477, 1989
42. McArthur KE, Wood CL, O'Dorisio MS, Zhou ZC, Gardner JD, Jensen RT: Characterization of receptors for VIP on pancreatic acinar cell plasma membranes using covalent cross-linking. Am J Physiol 252:G404, 1987
43. Wood CL, O'Dorisio MS, Vassalo LM, Malarkey WB, O'Dorisio TM: Vasoactive intestinal peptide effects on GH3 pituitary tumor cells: high affinity binding, affinity labeling, and adenylate cyclase stimulation. Comparison with peptide histidine isoleucine and growth hormone-releasing factor. Regul Pept 12:237, 1985